Cite
Min HK, Sung SA, Chung W, et al. Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease. Kidney Blood Press Res. 2021;46(4):460-468doi: 10.1159/000516029.
Min, H. K., Sung, S. A., Chung, W., Kim, Y. H., Chae, D. W., Ahn, C., Oh, K. H., Park, S. K., & Lee, S. W. (2021). Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease. Kidney & blood pressure research, 46(4), 460-468. https://doi.org/10.1159/000516029
Min, Hyang Ki, et al. "Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease." Kidney & blood pressure research vol. 46,4 (2021): 460-468. doi: https://doi.org/10.1159/000516029
Min HK, Sung SA, Chung W, Kim YH, Chae DW, Ahn C, Oh KH, Park SK, Lee SW. Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease. Kidney Blood Press Res. 2021;46(4):460-468. doi: 10.1159/000516029. Epub 2021 Jun 04. PMID: 34091449.
Copy
Download .nbib